---
title: 'Smoldering Multiple Myeloma : Taking the narrow over the wide path?'
date: '2024-03-01'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38427775/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240302170431&v=2.18.0.post9+e462414
source: Blood
description: Smoldering multiple myeloma (SMM) is an asymptomatic clonal plasma cells
  condition considered as a pre-malignant entity that may evolve overtime to symptomatic
  MM. Based on a "poorly defined" risk of progression, some well-intended investigators
  proposed prospective interventional trials for these individuals. We believe this
  may be a harmful intervention and favor a close « wait and watch » approach, and
  rather enroll these patients in dedicated observational biological studies aiming
  to ...
disable_comments: true
---
Smoldering multiple myeloma (SMM) is an asymptomatic clonal plasma cells condition considered as a pre-malignant entity that may evolve overtime to symptomatic MM. Based on a "poorly defined" risk of progression, some well-intended investigators proposed prospective interventional trials for these individuals. We believe this may be a harmful intervention and favor a close « wait and watch » approach, and rather enroll these patients in dedicated observational biological studies aiming to ...